Eric Topol October 5, 2024

The beginnings of a quiet revolution in high-throughput proteomics and A.I.

Last week in Science, I published an essay entitled “The revolution in high-throughput proteomics and AI.” But in the few weeks since I wrote it, there’s been much more to add to the story. Let me first summarize the background and we’ll build from there.

Background

The recent capability to measure thousands of plasma proteins from a tiny blood sample has provided a new dimension of expansive data that can advance our understanding of human health. For example, the company SomaLogic has developed the means to measure 11,000 proteins and Thermo Fisher’s Olink assays over 5,400 proteins from as little as 2 μl. (This is real; not Theranos!] When...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article